The Clorox Company(CLX)Earnings, Financials & Key Ratios

CLX•NYSE

$90.01

$10.88B mkt cap·13.8× P/E·Price updated May 6, 2026

SectorConsumer Defensive IndustryHousehold Products Sub-IndustryHousehold Cleaning and Paper Goods

AboutThe Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States. The Household segment provides cat litter products under the Fresh Step and Scoop Away brands; bags and wraps under the Glad brand; and grilling products under the Kingsford brand in the United States. The Lifestyle segment offers dressings, dips, seasonings, and sauces primarily under the Hidden Valley brand; natural personal care products under the Burt's Bees brand; and water-filtration products under the Brita brand in the United States. The International segment provides laundry additives; home care products; water-filtration systems; digestive health products; grilling products; cat litter products; food products; bags and wraps; natural personal care products; and professional cleaning and disinfecting products internationally primarily under the Clorox, Ayudin, Clorinda, Poett, Pine-Sol, Glad, Brita, RenewLife, Ever Clean and Burt's Bees brands. The Clorox Company sells its products primarily through mass retailers; grocery outlets; warehouse clubs; dollar stores; home hardware centers; drug, pet and military stores; third-party and owned e-commerce channels; and distributors, as well as a direct sales force The company was founded in 1913 and is headquartered in Oakland, California.Show more

Revenue$7.1B+0.2%
EBITDA$1.4B+21.5%
Net Income$810M+189.3%
EPS (Diluted)6.52+189.8%
Gross Margin44.96%+5.4%
EBITDA Margin19.68%+21.3%
Operating Margin16.6%+28.5%
Net Margin11.4%+188.8%
ROE166.32%+161.4%
ROIC27.68%+23.7%
Debt/Equity5.98+1.3%
Interest Coverage11.67+140.0%

Analysis→Technical→

CLX Key Insights

The Clorox Company (CLX) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

✓Dividend Aristocrat: 26 years of consecutive increases
✓Excellent 3Y average ROE of 85.5%
✓Strong Piotroski F-Score: 7/9
✓High quality earnings: Operating CF exceeds net income
✓Healthy dividend yield of 5.4%
✓Efficient asset utilization: 1.3x turnover

✗Weaknesses

✗High debt to equity ratio of 6.0x
✗Weak momentum: RS Rating 15 (bottom 15%)
✗Trading more than 30% below 52-week high
✗Expensive at 23.2x book value

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

CLX Price & Volume

The Clorox Company (CLX) stock price & volume — 10-year historical chart

Loading chart...

CLX Growth Metrics

The Clorox Company (CLX) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years2.31%

5 Years1.11%

3 Years-0.01%

TTM-3.69%

Profit CAGR

10 Years3.4%

5 Years-2.91%

3 Years20.58%

TTM8.93%

EPS CAGR

10 Years4.08%

5 Years-2.37%

3 Years20.46%

TTM10.79%

Return on Capital

10 Years28.53%

5 Years23.11%

3 Years24.06%

Last Year30.16%

CLX Recent Earnings

The Clorox Company (CLX) EPS & revenue vs analyst estimates — last 4 quarters

Full history →

●Beat EPS 10/12 qtrs (83%)●Beat Revenue 8/12 qtrs (67%)

Q2 2026Latest

Apr 30, 2026

EPS

$1.64

Est $1.55

+5.8%

Revenue

$1.7B

Est $1.7B

+0.0%

Q1 2026

Feb 3, 2026

EPS

$1.39

Est $1.43

-2.8%

Revenue

$1.7B

Est $1.6B

+2.0%

Q4 2025

Nov 3, 2025

EPS

$0.85

Est $0.82

+3.9%

Revenue

$1.4B

Est $1.4B

+2.1%

Q3 2025

Jul 31, 2025

EPS

$2.87

Est $2.20

+30.5%

Revenue

$2.0B

Est $1.9B

+3.1%

Quarter	Date	EPS (Act vs Est)	Revenue (Act vs Est)
Q2 2026Latest	Apr 30, 2026	$1.64vs $1.55+5.8%	$1.7Bvs $1.7B+0.0%
Q1 2026	Feb 3, 2026	$1.39vs $1.43-2.8%	$1.7Bvs $1.6B+2.0%
Q4 2025	Nov 3, 2025	$0.85vs $0.82+3.9%	$1.4Bvs $1.4B+2.1%
Q3 2025	Jul 31, 2025	$2.87vs $2.20+30.5%	$2.0Bvs $1.9B+3.1%

Based on last 12 quarters of dataView full earnings history →

Company	Market Cap	Stock Price	P/E Ratio (TTM)	Revenue Growth 1Y	Net Margin	Return on Equity (ROE)	Debt / Equity
CHDChurch & Dwight Co., Inc.Direct Competitor	22.49B	94.96	31.44	1.57%	11.81%	17.45%	0.55
SPBSpectrum Brands Holdings, Inc.Direct Competitor	1.98B	85.03	22.03	-5.23%	3.76%	5.52%	0.34
ENREnergizer Holdings, Inc.Direct Competitor	1.3B	18.97	5.71	2.28%	6.55%	116.9%	20.79
RCKYRocky Brands, Inc.Direct Competitor	273.2M	36.23	12.24	6.22%	4.62%	9.15%	0.49
PGThe Procter & Gamble CompanyProduct Competitor	345.67B	147.93	22.72	0.29%	14.66%	23.78%	0.68
KMBKimberly-Clark CorporationProduct Competitor	32.93B	99.19	16.34	-14.17%	12.81%	131.68%	4.34
COTYCoty Inc.Product Competitor	2.33B	2.65	-6.02	-3.68%	-9.26%	-14.21%	1.07
EPCEdgewell Personal Care CompanyProduct Competitor	1.05B	22.38	42.22	-1.34%	-3.69%	-5.14%	0.99

Compare CLX vs Peers

The Clorox Company (CLX) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs CHD

Most directly comparable listed peer for CLX.

Scale Benchmark

vs AMZN

Larger-name benchmark to compare CLX against a more recognizable public peer.

Peer Set

Compare Top 5

vs CHD, SPB, ENR, RCKY

CLX Income Statement

The Clorox Company (CLX) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily

Line item	Jun'17	Jun'18	Jun'19	Jun'20	Jun'21	Jun'22	Jun'23	Jun'24	Jun'25	TTM
Sales/Revenue	5.97B	6.12B	6.21B	6.72B	7.34B	7.11B	7.39B	7.09B	7.1B	6.76B
Revenue Growth %	3.68%	2.53%	1.47%	8.16%	9.22%	-3.19%	3.97%	-4.01%	0.16%	-3.69%
Cost of Goods Sold	3.31B	3.46B	3.5B	3.67B	4.16B	4.62B	4.52B	4.07B	3.91B	3.8B
COGS % of Revenue	55.37%	56.5%	56.37%	54.56%	56.67%	64.95%	61.14%	57.35%	55.04%	-
Gross Profit	2.67B▲ 0%	2.66B▼ 0.1%	2.71B▲ 1.8%	3.05B▲ 12.7%	3.18B▲ 4.2%	2.49B▼ 21.7%	2.87B▲ 15.3%	3.02B▲ 5.4%	3.19B▲ 5.6%	2.96B▲ 0%
Gross Margin %	44.63%	43.5%	43.63%	45.44%	43.33%	35.05%	38.86%	42.65%	44.96%	43.77%
Gross Profit Growth %	2.46%	-0.07%	1.76%	12.65%	4.16%	-21.69%	15.25%	5.36%	5.59%	-
Operating Expenses	1.54B	1.54B	1.6B	1.79B	1.94B	1.79B	2.04B	2.11B	2.02B	1.88B
OpEx % of Revenue	25.85%	25.13%	25.81%	26.62%	26.47%	25.26%	27.66%	29.73%	28.36%	-
Selling, General & Admin	1.41B	1.41B	1.47B	1.64B	1.79B	1.66B	1.91B	1.98B	1.89B	1.77B
SG&A % of Revenue	23.59%	22.98%	23.62%	24.46%	24.44%	23.4%	25.78%	27.96%	26.66%	-
Research & Development	135M	132M	136M	145M	149M	132M	138M	126M	121M	116M
R&D % of Revenue	2.26%	2.16%	2.19%	2.16%	2.03%	1.86%	1.87%	1.78%	1.7%	-
Other Operating Expenses	0	0	0	0	0	0	0	0	0	0
Operating Income	1.12B▲ 0%	1.13B▲ 0.3%	1.11B▼ 1.6%	1.26B▲ 14.3%	1.24B▼ 2.1%	696M▼ 43.8%	827M▲ 18.8%	916M▲ 10.8%	1.18B▲ 28.7%	1.07B▲ 0%
Operating Margin %	18.78%	18.37%	17.81%	18.82%	16.86%	9.79%	11.19%	12.91%	16.6%	15.9%
Operating Income Growth %	5.06%	0.27%	-1.6%	14.27%	-2.13%	-43.78%	18.82%	10.76%	28.71%	-
EBITDA	1.28B	1.29B	1.29B	1.44B	1.45B	920M	1.06B	1.15B	1.4B	1.3B
EBITDA Margin %	21.51%	21.1%	20.74%	21.48%	19.72%	12.95%	14.39%	16.23%	19.68%	19.25%
EBITDA Growth %	4.22%	0.54%	-0.23%	12.02%	0.28%	-36.46%	15.54%	8.28%	21.46%	-0.46%
D&A (Non-Cash Add-back)	163M	167M	182M	179M	210M	224M	236M	235M	219M	226M
EBIT	1.11B	1.13B	1.11B	1.28B	993M	704M	341M	501M	1.18B	1.1B
Net Interest Income	-78M	-73M	-88M	-91M	-88M	-92M	-87M	-80M	-92M	-101M
Interest Income	4M	6M	3M	2M	5M	5M	16M	23M	9M	5M
Interest Expense	82M	79M	91M	93M	93M	97M	103M	103M	101M	106M
Other Income/Expense	-89M	-71M	-83M	-80M	-338M	-89M	-589M	-518M	-101M	-87M
Pretax Income	1.03B▲ 0%	1.05B▲ 2.0%	1.02B▼ 2.8%	1.19B▲ 15.7%	900M▼ 24.1%	607M▼ 32.6%	238M▼ 60.8%	398M▲ 67.2%	1.08B▲ 170.9%	988M▲ 0%
Pretax Margin %	17.29%	17.21%	16.48%	17.63%	12.26%	8.54%	3.22%	5.61%	15.17%	14.62%
Income Tax	330M	231M	204M	246M	181M	136M	77M	106M	254M	218M
Effective Tax Rate %	31.95%	21.92%	19.92%	20.76%	20.11%	22.41%	32.35%	26.63%	23.56%	22.06%
Net Income	701M▲ 0%	823M▲ 17.4%	820M▼ 0.4%	939M▲ 14.5%	710M▼ 24.4%	462M▼ 34.9%	149M▼ 67.7%	280M▲ 87.9%	810M▲ 189.3%	756M▲ 0%
Net Margin %	11.74%	13.44%	13.2%	13.97%	9.67%	6.5%	2.02%	3.95%	11.4%	11.18%
Net Income Growth %	8.18%	17.4%	-0.36%	14.51%	-24.39%	-34.93%	-67.75%	87.92%	189.29%	8.93%
Net Income (Continuing)	703M	823M	820M	939M	719M	471M	161M	292M	824M	770M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	181M	173M	168M	164M	161M	159M
EPS (Diluted)	5.33▲ 0%	6.25▲ 17.3%	6.32▲ 1.1%	7.35▲ 16.3%	5.58▼ 24.1%	3.73▼ 33.2%	1.20▼ 67.8%	2.25▲ 87.5%	6.52▲ 189.8%	6.21▲ 0%
EPS Growth %	8.33%	17.26%	1.12%	16.3%	-24.08%	-33.15%	-67.83%	87.5%	189.78%	10.79%
EPS (Basic)	5.43	6.37	6.42	7.46	5.65	3.75	1.21	2.25	6.56	-
Diluted Shares Outstanding	131.57M	131.58M	129.79M	127.67M	127.3M	123.91M	124.18M	124.8M	124.29M	121.79M
Basic Shares Outstanding	128.95M	129.29M	127.73M	125.83M	125.57M	123.11M	123.59M	124.17M	123.53M	121.36M
Dividend Payout Ratio	58.77%	54.68%	59.76%	56.76%	78.59%	123.59%	391.28%	212.5%	74.32%	-

CLX Balance Sheet

The Clorox Company (CLX) balance sheet — assets, liabilities & shareholders' equity

Line item	Jun'17	Jun'18	Jun'19	Jun'20	Jun'21	Jun'22	Jun'23	Jun'24	Jun'25	TTM
Total Current Assets	1.51B	1.31B	1.3B	2.02B	1.83B	1.73B	1.83B	1.62B	1.61B	2.65B
Cash & Short-Term Investments	418M	131M	111M	871M	319M	183M	367M	202M	167M	1.19B
Cash Only	418M	131M	111M	871M	319M	183M	367M	202M	167M	1.19B
Short-Term Investments	0	0	0	0	0	0	0	0	0	0
Accounts Receivable	565M	600M	631M	648M	604M	681M	688M	695M	821M	671M
Days Sales Outstanding	34.53	35.76	37.06	35.19	30.03	34.97	33.99	35.76	42.18	38.69
Inventory	459M	506M	512M	454M	752M	755M	696M	637M	523M	588M
Days Inventory Outstanding	50.66	53.38	53.35	45.19	65.98	59.7	56.23	57.15	48.82	55.12
Other Current Assets	0	0	0	0	0	0	77M	88M	97M	205M
Total Non-Current Assets	3.06B	3.75B	3.81B	4.19B	4.5B	4.43B	4.12B	4.13B	3.95B	3.79B
Property, Plant & Equipment	931M	996M	1.03B	1.39B	1.63B	1.68B	1.69B	1.68B	1.6B	1.59B
Fixed Asset Turnover	6.42x	6.15x	6.01x	4.82x	4.49x	4.24x	4.37x	4.23x	4.44x	4.24x
Goodwill	1.2B	1.6B	1.59B	1.58B	1.57B	1.56B	1.25B	1.23B	1.23B	1.23B
Intangible Assets	722M	929M	912M	894M	918M	884M	712M	681M	566M	49M
Long-Term Investments	0	0	0	0	0	0	0	0	0	0
Other Non-Current Assets	210M	222M	274M	328M	378M	315M	462M	545M	558M	2.94B
Total Assets	4.57B▲ 0%	5.06B▲ 10.6%	5.12B▲ 1.1%	6.21B▲ 21.4%	6.33B▲ 1.9%	6.16B▼ 2.8%	5.95B▼ 3.5%	5.75B▼ 3.3%	5.56B▼ 3.3%	6.44B▲ 0%
Asset Turnover	1.31x	1.21x	1.21x	1.08x	1.16x	1.15x	1.24x	1.23x	1.28x	1.17x
Asset Growth %	1.22%	10.65%	1.11%	21.44%	1.95%	-2.78%	-3.46%	-3.26%	-3.3%	14.67%
Total Current Liabilities	1.81B	1.2B	1.44B	1.42B	2.06B	1.78B	1.92B	1.57B	1.92B	3.15B
Accounts Payable	501M	507M	507M	575M	930M	960M	1.02B	950M	838M	0
Days Payables Outstanding	55.3	53.48	52.83	57.23	81.6	75.91	82.48	85.24	78.23	66.38
Short-Term Debt	804M	199M	396M	0	300M	237M	50M	4M	4M	1.68B
Deferred Revenue (Current)	0	0	0	0	0	0	0	0	0	0
Other Current Liabilities	162M	154M	158M	288M	219M	176M	262M	190M	179M	1.48B
Current Ratio	0.84x	1.09x	0.91x	1.42x	0.89x	0.97x	0.95x	1.03x	0.84x	0.84x
Quick Ratio	0.58x	0.67x	0.55x	1.10x	0.52x	0.54x	0.59x	0.63x	0.57x	0.57x
Cash Conversion Cycle	29.89	35.66	37.58	23.15	14.41	18.76	7.73	7.68	12.78	27.43
Total Non-Current Liabilities	2.22B	3.13B	3.12B	3.89B	3.69B	3.65B	3.64B	3.69B	3.16B	3.19B
Long-Term Debt	1.39B	2.28B	2.29B	2.78B	2.48B	2.47B	2.48B	2.48B	2.48B	2.81B
Capital Lease Obligations	0	0	0	278M	301M	314M	310M	334M	305M	591M
Deferred Tax Liabilities	61M	72M	50M	62M	67M	66M	28M	22M	20M	82M
Other Non-Current Liabilities	770M	778M	780M	767M	834M	791M	825M	848M	351M	1.46B
Total Liabilities	4.03B	4.33B	4.56B	5.3B	5.74B	5.43B	5.56B	5.26B	5.08B	6.34B
Total Debt	2.19B	2.48B	2.68B	3.12B	3.17B	3.1B	2.92B	2.9B	2.88B	4.49B
Net Debt	1.78B	2.35B	2.57B	2.25B	2.85B	2.92B	2.56B	2.7B	2.71B	3.3B
Debt / Equity	4.05x	3.42x	4.80x	3.44x	5.35x	4.26x	7.54x	5.90x	5.98x	5.98x
Debt / EBITDA	1.71x	1.92x	2.08x	2.16x	2.19x	3.37x	2.75x	2.52x	2.06x	3.45x
Net Debt / EBITDA	1.38x	1.82x	2.00x	1.56x	1.97x	3.17x	2.41x	2.35x	1.94x	1.94x
Interest Coverage	13.60x	14.24x	12.25x	13.74x	10.68x	7.26x	3.31x	4.86x	11.67x	10.38x
Total Equity	542M▲ 0%	726M▲ 33.9%	559M▼ 23.0%	908M▲ 62.4%	592M▼ 34.8%	729M▲ 23.1%	388M▼ 46.8%	492M▲ 26.8%	482M▼ 2.0%	92M▲ 0%
Equity Growth %	82.49%	33.95%	-23%	62.43%	-34.8%	23.14%	-46.78%	26.8%	-2.03%	-163.08%
Book Value per Share	4.12	5.52	4.31	7.11	4.65	5.88	3.12	3.94	3.88	0.76
Total Shareholders' Equity	542M	726M	559M	908M	411M	556M	220M	328M	321M	-67M
Common Stock	159M	159M	159M	159M	131M	131M	131M	131M	131M	131M
Retained Earnings	2.44B	2.8B	3.15B	3.57B	1.04B	1.05B	583M	250M	432M	223M
Treasury Stock	-2.44B	-2.66B	-3.19B	-3.31B	-1.4B	-1.35B	-1.25B	-1.19B	-1.4B	0
Accumulated OCI	-543M	-547M	-602M	-640M	-546M	-479M	-493M	-155M	-157M	-152M
Minority Interest	0	0	0	0	181M	173M	168M	164M	161M	159M

CLX Cash Flow Statement

The Clorox Company (CLX) cash flow — operating, investing & free cash flow history

Line item	Jun'17	Jun'18	Jun'19	Jun'20	Jun'21	Jun'22	Jun'23	Jun'24	Jun'25	TTM
Cash from Operations	868M	974M	992M	1.55B	1.28B	786M	1.16B	695M	981M	981M
Operating CF Margin %	14.53%	15.9%	15.96%	23%	17.38%	11.06%	15.67%	9.8%	13.81%	-
Operating CF Growth %	11.57%	12.21%	1.85%	55.85%	-17.46%	-38.4%	47.33%	-39.98%	41.15%	-141.33%
Net Income	703M	823M	820M	939M	719M	471M	161M	292M	824M	756M
Depreciation & Amortization	163M	166M	180M	180M	211M	224M	236M	235M	219M	226M
Stock-Based Compensation	51M	53M	43M	50M	50M	52M	73M	74M	81M	66M
Deferred Taxes	-35M	-23M	-20M	-2M	-32M	5M	-149M	-100M	-18M	133M
Other Non-Cash Items	30M	44M	-29M	30M	339M	133M	483M	435M	86M	-438M
Working Capital Changes	-47M	-88M	-2M	349M	-11M	-99M	354M	-241M	-211M	-173M
Change in Receivables	-1M	-24M	-32M	-27M	82M	-84M	-13M	-34M	-145M	-216M
Change in Inventory	-19M	-21M	-7M	50M	-282M	-18M	58M	55M	63M	53M
Change in Payables	-34M	-47M	17M	291M	311M	-47M	157M	-140M	-124M	-49M
Cash from Investing	-205M	-859M	-196M	-252M	-452M	-229M	-223M	-175M	-94M	-196M
Capital Expenditures	-231M	-194M	-206M	-254M	-331M	-251M	-228M	-212M	-220M	-196M
CapEx % of Revenue	3.87%	3.17%	3.32%	3.78%	4.51%	3.53%	3.09%	2.99%	3.1%	-
Acquisitions	0	-681M	0	0	-85M	0	0	17M	128M	0
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	26M	16M	10M	2M	-36M	22M	5M	20M	-2M	0
Cash from Financing	-645M	-399M	-815M	-523M	-1.39B	-689M	-753M	-655M	-924M	578M
Debt Issued (Net)	-125M	277M	189M	96M	0	-83M	-188M	-45M	0	253M
Equity Issued (Net)	-108M	-226M	-514M	-86M	-802M	-20M	33M	1M	-306M	-79M
Dividends Paid	-412M	-450M	-490M	-533M	-558M	-571M	-583M	-595M	-602M	-602M
Share Repurchases	-183M	-271M	-661M	-248M	-905M	-25M	0	0	-332M	-61M
Other Financing	0	0	0	0	-31M	-15M	-15M	-16M	-16M	1.01B
Net Change in Cash	17M▲ 0%	-287M▼ 1788.2%	-21M▲ 92.7%	766M▲ 3747.6%	-555M▼ 172.5%	-138M▲ 75.1%	182M▲ 231.9%	-161M▼ 188.5%	-37M▲ 77.0%	958M▲ 0%
Free Cash Flow	637M▲ 0%	780M▲ 22.4%	786M▲ 0.8%	1.29B▲ 64.4%	945M▼ 26.9%	535M▼ 43.4%	930M▲ 73.8%	483M▼ 48.1%	761M▲ 57.6%	380M▲ 0%
FCF Margin %	10.66%	12.74%	12.65%	19.22%	12.87%	7.53%	12.59%	6.81%	10.71%	5.62%
FCF Growth %	5.12%	22.45%	0.77%	64.38%	-26.86%	-43.39%	73.83%	-48.06%	57.56%	-52.56%
FCF per Share	4.84	5.93	6.06	10.12	7.42	4.32	7.49	3.87	6.12	6.12
FCF Conversion (FCF/Net Income)	1.24x	1.18x	1.21x	1.65x	1.80x	1.70x	7.77x	2.48x	1.21x	0.50x
Interest Paid	78M	75M	87M	89M	89M	89M	99M	102M	97M	0
Taxes Paid	347M	245M	207M	241M	303M	100M	73M	347M	264M	0

CLX Key Ratios

The Clorox Company (CLX) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric	2017	2018	2019	2020	2021	2022	2023	2024	2025	TTM
Return on Equity (ROE)	167.1%	129.81%	127.63%	128.02%	94.67%	69.95%	26.68%	63.64%	166.32%	404.82%
Return on Invested Capital (ROIC)	37.18%	31.27%	26.74%	30.17%	28.14%	14.73%	18.81%	22.39%	27.68%	27.68%
Gross Margin	44.63%	43.5%	43.63%	45.44%	43.33%	35.05%	38.86%	42.65%	44.96%	43.77%
Net Margin	11.74%	13.44%	13.2%	13.97%	9.67%	6.5%	2.02%	3.95%	11.4%	11.18%
Debt / Equity	4.05x	3.42x	4.80x	3.44x	5.35x	4.26x	7.54x	5.90x	5.98x	5.98x
Interest Coverage	13.60x	14.24x	12.25x	13.74x	10.68x	7.26x	3.31x	4.86x	11.67x	10.38x
FCF Conversion	1.24x	1.18x	1.21x	1.65x	1.80x	1.70x	7.77x	2.48x	1.21x	0.50x
Revenue Growth	3.68%	2.53%	1.47%	8.16%	9.22%	-3.19%	3.97%	-4.01%	0.16%	-3.69%

CLX SEC Filings & Documents

The Clorox Company (CLX) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

Material company update

Apr 30, 2026·SEC

Material company update

Apr 1, 2026·SEC

Material company update

Mar 10, 2026·SEC

10-K Annual Reports

FY 2025

Aug 8, 2025·SEC

FY 2024

Aug 8, 2024·SEC

10-Q Quarterly Reports

FY 2026

Apr 30, 2026·SEC

FY 2026

Feb 3, 2026·SEC

FY 2025

Nov 3, 2025·SEC

CLX Frequently Asked Questions

The Clorox Company (CLX) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

The Clorox Company (CLX) reported $6.76B in revenue for fiscal year 2025. This represents a 205% increase from $2.22B in 1996.

The Clorox Company (CLX) grew revenue by 0.2% over the past year. Growth has been modest.

Yes, The Clorox Company (CLX) is profitable, generating $756.0M in net income for fiscal year 2025 (11.4% net margin).

Dividend & Returns

Yes, The Clorox Company (CLX) pays a dividend with a yield of 5.38%. This makes it attractive for income-focused investors.

The Clorox Company (CLX) has a return on equity (ROE) of 166.3%. This is excellent, indicating efficient use of shareholder capital.

The Clorox Company (CLX) generated $380.0M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

Explore More CLX

The Clorox Company (CLX) financial analysis — history, returns, DCA and operating performance tools

Full CLX Stock Analysis

Analyst verdict, bull/bear case, risk factors and peer comparison

→

Total Return Calculator

Historical returns with dividends reinvested

→

DCA Calculator

Dollar cost averaging vs lump sum

→

Dividend History

Yield, growth, payout safety & DRIP

→

Earnings History

EPS trends, net income & profitability

→

Price History

Long-term charts & historical price data

→

Revenue History

Sales growth patterns & revenue breakdown

→

Financial Ratios

30 years of market, efficiency and balance-sheet ratios

→

Valuation

DCF intrinsic value, peer multiples & estimates

→

The Clorox Company(CLX)Earnings, Financials & Key Ratios

CLX Key Insights

✓Strengths

✗Weaknesses

CLX Price & Volume

CLX Growth Metrics

Revenue CAGR

Profit CAGR

EPS CAGR

Return on Capital

CLX Recent Earnings

CLX Peer Comparison

Compare CLX vs Peers

vs CHD

vs AMZN

Compare Top 5

CLX Income Statement

CLX Balance Sheet

CLX Cash Flow Statement

CLX Key Ratios

CLX SEC Filings & Documents

8-K Announcements

10-K Annual Reports

10-Q Quarterly Reports

CLX Frequently Asked Questions

Explore More CLX

Full CLX Stock Analysis

Total Return Calculator

DCA Calculator

Dividend History

Earnings History

Price History

Revenue History

Financial Ratios

Valuation